isha
New Member
Posts: 11
Status: Offline
Joined:
msn yahoo aim google icq xfire | | Infectious Disease Rapid Diagnostic Testing Market (13th Dec 24 at 10:15am UTC) | Quote Reply | The global infectious disease rapid diagnostic testing market size is expected to reach USD 51.01 Billion in 2030 and register a revenue CAGR of 7.0% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of infectious diseases and emergence of COVID-19 are some key factors driving market revenue growth. Prevalence of infectious diseases has been rising, in both developed and developing countries, and resulting in steady demand for infectious disease rapid diagnostic testing. Following the pandemic, the need to identify and monitor infectious diseases has been placed on significantly high importance and has driven major increase in demand for testing kits. Moreover, rising preference for preventive care is expected to increase need for infectious disease diagnostics over the forecast period. Large-scale population-based testing is necessary to strengthen COVID-19 preventive and control efforts and measures, which is expected to continue to drive increased demand for infectious disease diagnostic products in future.
The global Infectious Disease Rapid Diagnostic Testing market research report offers extensive statistical analysis to impart a deeper understanding of the Infectious Disease Rapid Diagnostic Testing industry and the changing dynamics of the business sphere. The report covers key data about market share, market size, revenue growth, sales and distribution channel, current and emerging trends, and technological advancements. The report offers a comprehensive overview of the Infectious Disease Rapid Diagnostic Testing industry to assist the companies engaged in the market to maximize the return on their investments and capitalize on the emerging growth prospects.
Available Sample Report in PDF Version@ https://www.emergenresearch.com/request-sample/269
Competitive Terrain:
The global Infectious Disease Rapid Diagnostic Testing industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
The leading market contenders listed in the report are:
Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Corporation, BioMérieux SA, BD (Becton, Dickinson, and Company), Siemens Healthineers AG, PerkinElmer Inc., Bio-Rad Laboratories, Inc., and Sysmex Corporation
Additional information offered by the report:
Along with a complete overview of the global Infectious Disease Rapid Diagnostic Testing market, the report provides detailed scrutiny of the diverse market trends observed on both regional and global levels.
The report elaborates on the global Infectious Disease Rapid Diagnostic Testing market size and share governed by the major geographies.
It performs a precise market growth forecast analysis, cost analysis, and a study of the micro- and macro-economic indicators.
It further presents a detailed description of the company profiles of the key market contenders.
To seek a discount on this report, click on the link: @ https://www.emergenresearch.com/request-discount/269 | |
|
